![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Leukemia |
Free Subscription
2 Am J Hematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
Intrathecal Prophylaxis with 12 Versus 8 Administrations Reduces the Incidence of
Central Nervous System Relapse in Patients with Newly Diagnosed Philadelphia
Chromosome Positive Acute Lymphoblastic Leukemia.
Am J Hematol. 2022 May 28. doi: 10.1002/ajh.26622.
PubMed
TP53-altered chronic lymphocytic leukemia treated with firstline Bruton's
tyrosine kinase inhibitor-based therapy: A retrospective analysis.
Am J Hematol. 2022 May 14. doi: 10.1002/ajh.26595.
PubMed
Abstract available
Outcome prediction of chronic myeloid leukemia (CML) in children.
Ann Hematol. 2022 Jun 1. pii: 10.1007/s00277-022-04852.
PubMed
Abstract available
Oncology stewardship in acute myeloid leukemia.
Ann Hematol. 2022 May 26. pii: 10.1007/s00277-022-04872.
PubMed
Abstract available
Recurrent non-coding somatic and germline WT1 variants converge to disrupt MYB
binding in acute promyelocytic leukemia.
Blood. 2022 Jun 2. pii: 485457. doi: 10.1182/blood.2021014945.
PubMed
Abstract available
Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia
and other high-risk myeloid malignancies after undergoing sequential conditioning
regimen based on IDA-FLAG and high-dose melphalan.
Bone Marrow Transplant. 2022 May 28. pii: 10.1038/s41409-022-01703.
PubMed
Abstract available
Venetoclax for arsenic-resistant acute promyelocytic leukaemia.
Br J Haematol. 2022;197:e58-e60.
PubMed
Updated revision of the British Society of Haematology guidelines for chronic
lymphocytic leukaemia.
Br J Haematol. 2022;197:513-514.
PubMed
Guideline for the treatment of chronic lymphocytic leukaemia.
Br J Haematol. 2022;197:544-557.
PubMed
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk
factors, radiological patterns and evolution in a single-centre cohort.
Br J Haematol. 2022;197:602-608.
PubMed
Abstract available
Efficacy of conventional-dose cytarabine, idarubicin and thioguanine (IAT) versus
intermediate-dose cytarabine and idarubicin (IdAraC-Ida) in the induction
treatment of AML: long-term results of the prospective randomized nationwide
AML-2003 study by
Eur J Haematol. 2022 May 30. doi: 10.1111/ejh.13805.
PubMed
Abstract available
Typical, atypical and cryptic t(15;17)(q24;q21) (PML::RARA) observed in acute
promyelocytic leukemia: a retrospective review of 831 patients with concurrent
chromosome and PML::RARA dual-color dual-fusion FISH studies.
Genes Chromosomes Cancer. 2022 May 31. doi: 10.1002/gcc.23070.
PubMed
Abstract available
A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients
in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia
(INO-Ped-ALL-1).
Int J Hematol. 2022 May 30. pii: 10.1007/s12185-022-03388.
PubMed
Abstract available
Effect of BCG HSP70 Gene Transfection on Dendritic Cells Derived From Bone Marrow
in Children With Acute Leukemia.
J Pediatr Hematol Oncol. 2022 May 11. pii: 00043426-990000000-00036.
PubMed
Abstract available
Prognostic scoring systems and risk stratification in myelodysplastic syndrome:
focus on integration of molecular profile.
Leuk Lymphoma. 2022;63:1281-1291.
PubMed
Abstract available
The treatment landscape for Relapsed Refractory B Acute Lymphoblastic Leukaemia
(ALL).
Leuk Lymphoma. 2022;63:1292-1301.
PubMed
Abstract available
Progressive multifocal leukoencephalopathy post ibrutinib therapy in relapsed
chronic lymphocytic leukaemia.
Leuk Lymphoma. 2022;63:1464-1468.
PubMed
Abstract available
Is ibrutinib the gold standard for therapy - naive elderly patients with CLL?
Leuk Lymphoma. 2022;63:1265-1266.
PubMed
Azacitidine, intensive chemotherapy or best supportive care in relapsed or
refractory acute myeloid leukemia, a DATAML registry study.
Leuk Lymphoma. 2022;63:1398-1406.
PubMed
Abstract available
The characteristics and clinical prognosis analysis of ASXL1 mutations in Chinese
adult patients with primary cytogenetically normal acute myeloid leukemia by
next-generation sequencing.
Leuk Lymphoma. 2022 Jun 2:1-9. doi: 10.1080/10428194.2022.2081323.
PubMed
Abstract available
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A
single-center experience.
Leuk Res. 2022;118:106861.
PubMed
Abstract available
ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in
t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemia.
Leuk Res. 2022;118:106872.
PubMed
Differential characteristics of TP53 alterations in pure erythroid leukemia
arising after exposure to cytotoxic therapy.
Leuk Res. 2022;118:106860.
PubMed
Abstract available
TH1 cytokines induce senescence in AML.
Leuk Res. 2022;117:106842.
PubMed
Abstract available
Predictive scoring systems for molecular responses in persons with chronic phase
chronic myeloid leukemia receiving initial imatinib therapy.
Leukemia. 2022 Jun 1. pii: 10.1038/s41375-022-01616.
PubMed
Abstract available
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid
leukemia: final results from the BFORE trial.
Leukemia. 2022 May 28. pii: 10.1038/s41375-022-01589.
PubMed
Abstract available
Germline PTPN13 mutations in patients with bone marrow failure and acute
lymphoblastic leukemia.
Leukemia. 2022 May 28. pii: 10.1038/s41375-022-01610.
PubMed
Regulation of proton partitioning in kinase-activating acute myeloid leukemia and
its therapeutic implication.
Leukemia. 2022 May 27. pii: 10.1038/s41375-022-01606.
PubMed
Abstract available
The bone marrow niche regulates redox and energy balance in MLL::AF9 leukemia
stem cells.
Leukemia. 2022 May 26. pii: 10.1038/s41375-022-01601.
PubMed
Abstract available
The emerging importance and evolving understanding of clonal hematopoiesis in
multiple myeloma.
Semin Oncol. 2022;49:19-26.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by